Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
How Does Empagliflozin Reduce Cardiovascular Mortality? Insights From a Mediation Analysis of the EMPA-REG OUTCOME Trial
PaperCitations, authors & open-access status
How Does Empagliflozin Reduce Cardiovascular Mortality? Insights From a Mediation Analysis of the EMPA-REG OUTCOME Trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 752 citations, 2017 year and closed oa status.
752
Citations
2017
Year
closed
OA Status